Autophagic receptor p62 protects against glycation‐derived toxicity and enhances viability
Open Access
- 4 November 2020
- journal article
- research article
- Published by Wiley in Aging Cell
- Vol. 19 (11) , e13257
Abstract
Diabetes and metabolic syndrome are associated with the typical American high glycemia diet and result in accumulation of high levels of advanced glycation end products (AGEs), particularly upon aging. AGEs form when sugars or their metabolites react with proteins. Associated with a myriad of age‐related diseases, AGEs accumulate in many tissues and are cytotoxic. To date, efforts to limit glycation pharmacologically have failed in human trials. Thus, it is crucial to identify systems that remove AGEs, but such research is scanty. Here, we determined if and how AGEs might be cleared by autophagy. Ourin vivomouse andC.elegansmodels, in which we altered proteolysis or glycative burden, as well as experiments in five types of cells, revealed more than six criteria indicating that p62‐dependent autophagy is a conserved pathway that plays a critical role in the removal of AGEs. Activation of autophagic removal of AGEs requires p62, and blocking this pathway results in accumulation of AGEs and compromised viability. Deficiency of p62 accelerates accumulation of AGEs in soluble and insoluble fractions. p62 itself is subject to glycative inactivation and accumulates as high mass species. Accumulation of p62 in retinal pigment epithelium is reversed by switching to a lower glycemia diet. Since diminution of glycative damage is associated with reduced risk for age‐related diseases, including age‐related macular degeneration, cardiovascular disease, diabetes, Alzheimer's, and Parkinson's, discovery of methods to limit AGEs or enhance p62‐dependent autophagy offers novel potential therapeutic targets to treat AGEs‐related pathologies.Keywords
Funding Information
- BrightFocus Foundation
This publication has 47 references indexed in Scilit:
- Late-life rapamycin treatment reverses age-related heart dysfunctionAging Cell, 2013
- The Hallmarks of AgingCell, 2013
- Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic MicePLOS ONE, 2013
- Autophagy modulates dynamics of connexins at the plasma membrane in a ubiquitin-dependent mannerMolecular Biology of the Cell, 2012
- Natural History of Age-Related Retinal Lesions That Precede AMD in Mice Fed High or Low Glycemic Index DietsInvestigative Ophthalmology & Visual Science, 2012
- Glycation‐altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age‐related disease (in nondiabetics)Aging Cell, 2011
- Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and TauJournal of Biological Chemistry, 2010
- C. elegans as Model for the Study of High Glucose– Mediated Life Span ReductionDiabetes, 2009
- Autophagy fights disease through cellular self-digestionNature, 2008
- Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegansAging Cell, 2008